Recursion Pharmaceuticals (RXRX) Other Non-Current Liabilities (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Other Non-Current Liabilities of $2.7 million for Q2 2026, up 72.7% from $1.57 million a year earlier and up 33.4% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals' Other Non-Current Liabilities came in at $2.08 million, down 56.0% from FY2024.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
- In prior years, Recursion Pharmaceuticals' Other Non-Current Liabilities was $4.73 million in FY2024 and $9.34 million in FY2021 (+244.9%).
- The Q2 2026 figure stands as the highest quarterly Other Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Other Non-Current Liabilities increased in 1 of the last five quarters, with an average decline of 30.9%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $2.03 million (Q1 2026), $2.08 million (Q4 2025) and $1.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Dec 31, 2021 | 9.34 Mn |
| Sep 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 2.82 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Dec 31, 2020 | 2.71 Mn |
API Access
Recursion Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();